Rheumatic aspects of acquired immunodeficiency syndrome

Current Opinion in Rheumatology

Volumn 8, Issue 4, 1996, Pages 346-353

  Itescu, Silviu ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; HYDROXYCHLOROQUINE; INDOMETACIN; PHOSPHOLIPID ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; B LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; THROMBOSIS;

EID: 0029763321     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199607000-00012     Document Type: Review

References (61)

1. Munson LG, Scott ME, Landay AL, Spear GT: Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection. Clin Immunol Immunopathol 1995, 75:20-25.
2. Saarloos M-N, Koenig RE, Spear GT: Elevated levels of iC3b and C4d. but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-1-associated myelopathy/tropical spastic paraparesis. J Infect Dis 1995, 172:1095-1097.
3. Solinger AM, Hess EV: Induction of autoantibodies by HIV infection and their significance. Rheum Dis Clin North Am 1991, 17:157-176.
4. Savige JA, Chang L, Horn S, et al.: Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994, 18:205-211.
5. Molina JF, Citera G, Rosler D, et al.: Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol 1995, 22:347-50.
6. Klaasen RJL, Goldschmeding R, Dolman KM, et al.: Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 1992, 87:24-30.
7. 2-glycoprotetn I, unlike those developing in autoimmune diseases. This result may provide an explanation for the lack of association between antiphospholipid antibodies in HIV-1 infection and thrombosis.
8. Gharavi AE, Sammaritano LR, Wen JY: Characteristics of human immunodeficiency virus and chlorpromazine-induced antiphospholipid antibodies-effect of β2-GP1 on binding to phospholipid. J Rheumatol 1994, 1:94-99.
9. Koike T: Anticardiolipin antibodies and β2-glycoprotein I. Clin Immunol Immunopathol 1994, 72:187-192.
10. Rubbert A, Bock E, Schwab J, et al.: Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT. Clin Exp Immunol 1994, 38:361-368.
11. Jaffe IA: Rheumatoid arthritis and AIDS. Mod Pathol 1994, 7:153-154.
12. Disla E, Reddy A, Stein S, et al.: Rheumatoid arthritis-HIV disease: persistence of arthritis with CD4 decline [abstract]. Arthritis Rheum 1994, 37(suppl 6):R41.
13. Ornstein MH, Kerr LD, Spiera H: A reexamination of the relationship between active rheumatoid arthritis and the acquired immunodeficiency syndrome. Arthritis Rheum 1995, 38:1701-1706. Case study and discussion of the previously reported cases of coexistence of rheumatoid arthritis and HIV-1, suggesting that this association may occur more frequently than hitherto appreciated.
14. Müller-Ladner U, Kriegsmann J, Gay RE, Koopman WJ, Gay S, Chatham WW: Progressive joint destruction in a human immunodeficiency virus-infected patient with rheumatoid arthritis. Arthritis Rheum 1995, 38:1328-1332. Histopathologic and immunohistologic study demonstrating ongoing joint destruction mediated by synovial macrophages and fibroblasts despite the absence of T cells in an HIV-infected individual, with implications for rheumatoid arthritis pathogenesis.
15. Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993, 52:S39-S47.
16. Winchester R, Brancato LR, Itescu S, et al.: Implications from the occurrence of Reiter's syndrome and related disorders in association with advanced HIV infection. Scand J Rheumatol 1988, 74:89-93.
17. Solinger AM, Hess EV: Rheumatic diseases and AIDS: is the association real? J Rheumatol 1993, 20:678-683.
18. Hochberg MC, Fox R, Nelson KE, Saah A: HIV infection is not associated with Reiter's syndrome: data from the Johns Hopkins Multicenter AIDS cohort study. AIDS 1990, 4:1149-1151.
19. Duvic M: Human immunodeficiency virus and the skin: selected controversies. J Invest Dermatol 1995, 105:117S-121S. Insightful and comprehensive review on major issues regarding HIV-1 and skin disease.
20. Winchester R, Bernstein DH, Fischer HD, et al.: The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987, 106:19-26.
21. Espinoza L, Aguilar J, Espinoza C, et al: HIV-associated arthropathy: HIV antigen demonstration in the synovial membrane. J Rheumatol 1990, 17:1195-1201.
22. Hughes RA, Macatonia SE, Rowe IF, et al: The detection of HIV DNA in dendritic cells from the joints of patients with aseptic arthritis. Br J Rheumatol 1990, 29:166-170.
23. Duvic M, Crane MM, Mahoney SE, et al: Zidovudine improves psoriasis in human immunodeficiency virus-positive males. Arch Dermatol 1994, 130:447-451.
24. Townsend B, Cohen P, Duvic M: Zidovudine improves psoriasis in HIV patients. J Am Acad Dermatol 1995, 32:994-999. Intriguing report suggesting that a proportion of HIV-negative persons with psoriasis may benefit from zidovudine treatment.
25. Bourinbaiar AS, Lee-Huang S: .The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication. FEBS Lett 1995, 360:85-88. The authors demonstrate that indomethacin specifically inhibits HIV replication and suggest a mechanism by which a new class of antiviral agents could be developed, providing a rationale for preferentially using this drug in HIV-associated arthritis.
26. Ornstein MH, Sperber K: The anti-inflammatory and antiviral effects of hydroxychloroquine in 2 patients with AIDS and active inflammatory arthritis [abstract]. Arthritis Rheum 1995, 37(suppl 9):S198. The authors suggest that hydroxychloroquine may be an effective agent in treating HIV-associated arthritis, possibly as a result of its action in inhibiting HIV-1 replication in macrophages and T cells.
27. Sperber K, Kalb TH, Stecher VJ, et al.: Inhibition of human immunodeficiency virus type I replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses 1993, 9:91-98.
28. Maurer TA, Zackheim HS, Tuffanelli L, et al.: The use of methotrexats for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol 1994, 31:372-375.
29. Louthrenoo W: Successful treatment of severe Reiter's syndrome associated with human immunodeficiency virus infection with etretinate. J Rheumatol 1993, 20:1243-1246.
30. Itescu S, Brancato U, Winchester R: A sicca syndrome in HIV infection: association with HLA-DRS and CDS lymphocytosls. Lancet 1989, ii:466-468.
31. Itescu S, Brancato L, Busbaum J, et al.: Diffuse infiltrative lymphocytosis syndrome (DILS) in HIV infection: a host immune response associated with HLA-DR5. Ann Intern Med 1990, 112:3-10.
32. Chisholm DM, Mason DK: Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968, 21:656.
33. Itescu S, Winchester R: Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in individuals infected with HIV-1 that may present as a slcca syndrome. Rheum Dis Clin North Am 1992, 18:683-697.
34. Itescu S, Dalton J, Zhang H-Z, Winchester R: Tissue infiltration in a CD8 lymphocytosis syndrome associated with HIV infection has the phenotype of an antigen driven process. J Clin Invest 1993, 91:2216-2225.
35. Dwyer E, Itescu S, Winchester R: Characterization of the primary structure of T cell receptor β chains in cells Infiltrating the salivary gland in the sicca syndrome of HIV-1 infection. J Clin Invest 1993, 92:496-502.
36. O'Brien WA, Koyanagi Y, Namazie A, et al.: HIV-1 tropism for mononu-clear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990, 348:69-73.
37. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253:71-73.
38. Itescu S, Rose S, Dwyer E, Winchester R: Certain DR5 and DR6 MHC class II alleles are associated with a CD8 lymphocytic host response to HIV-1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Nat Acad Sci U S A 1994, 91:11472-11476.
39. Itescu S, Rose S, Dwyer E, Winchester R: Different HLA-B locus peptide anchoring pockets may determine outcome in HIV-1 infection. Hum Immunol 1995, 42:81-89. The authors provide a rationale for analyzing MHC class I disease associations according to regions of shared structure and suggest that HLA-B locus anchoring pockets influence HIV-1 disease outcome, possibly by the type of immunogenic peptides they bind.
40. Itescu S, Mathur-Wagh U, Skovron ML, et al.: HLA-B35 is associated with accelerated progression to AIDS. J AIDS 1992, 5:37-45.
41. Till M, MacDonell KB: Myopathy with HIV-1 infection: HIV-1 or zidovudine? Ann Intern Med 1990, 113:492-493.
42. Dalakas MC, Pezeshkpour GH, Flaherty M: Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med 1987, 317:1602-1603.
43. Leon-Monzon M, Lamperth L, Dalakas MC: Search for HIV provirus DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle Nerve 1993, 16:408-413.
44. Wiley CA, Nerenberg M, Cros D, et al.: HTLV-1 polymyositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 1989, 320:992-995.
45. Beilke MA, Greenspan DL, Impey A, et al.: Laboratory study of HIV-1 and HTLV-I/II coinfection. J Med Virol 1994, 44:132-143.
46. Higuchi I, Hashimoto K, Kashio N, et al.: Detection of HTLV-1 provirus by in situ polymerase chain reaction in mononuclear Inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle Nerve 1995, 18:854-858. Demonstrates HTLV-I provirus to be present only in mononuclear cells, and not in myocytes, of patients with polymyositis, suggesting that myocyte damage results from immune mechanisms rather than from direct viral effects.
47. Beilke MA, Trana-Dorge V, England JD, et al.: Polymyositis, arthritis, and uveitis in a macaque experimentally infected with HTLV-1. Arthritis Rheum 1996, 39:610-615. Demonstration that polymyositis developed in a macaque infected with lymphocytes containing HTLV-I reinforces the importance of the host immune response, rather than direct effects of the virus, in mediating this disease.
48. Dalakas MC, Illa I, Pezeshkpour GH, et al.: Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990, 322:1098-1105.
49. Chariot P, Monnet I, Mouchet M, et al.: Determination of the blood lactate: pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis Rheum 1994, 37:583-586.
50. Calabrese LH: Vasculitis and infection with the human immunodeficlency virus. Rheum Dis Clin North Am 1991, 17:131-147.
51. Marks C, Kuskov S: Pattern of arterial aneurysms in acquired Immunodeficiency disease. World J Surg 1995, 19:127-132. Life-threatening necrotizing vasculitis of large vessels developing in association with HIV-1 infection.
52. Libman BS, Quismorio FP Jr, Stimmler MM: Polyarteritis nodosa-like vasculitis in human immunodeficiency virus infection. J Rheumatol 1995, 22:351-355.
53. Gherardi R, Belec L, Mhiri C, et al.: The spectrum of vasculitis in human immunodeficiency virus-infected patients: a clinicopathologic evaluation. Arthritis Rheum 1993, 36:1164-1174.
54. Anders KH, Latta H, Chang BS, et al.: Lymphold granulomatosis and malignant lymphoma of the central nervous system in acquired Immunodeficiency syndrome. Hum Pathol 1989, 20:326.
55. Golden MP, Hammer SM, Wanke CA, Albrecht MA: Cytomegalovirus vasculitis: case reports and review of the literature. Medicine 1994, 73:246-255.
56. Goldenberg DL: Septic arthritis and other infections of rheumatologic significance. Rheum Dis Clin North Am 1991, 17:149-156.
57. Pappo AS, Buchanan GR, Johnson A: Septic arthritis in children with hemophilia. Am J Dis Child 1989, 143:1226.
58. Medina F, Hermida C, Jara L, et al.: Staphylococcal arthritis in human Immunodeficiency virus Infection. Br J Rheumatol 1995, 34:397-398.
59. Guyot DR, Manoli All, Kling GA: Pyogenic sacroiliitis in IV drug abusers. AJR Am J Roentgenol 1987, 149:1209-1211.
60. Medina F, Fuentes M, Jara LJ, et al.: Salmonella pyomyositis in patients with the human immunodeficiency virus. Br J Rheumatol 1995, 34:568-571.
61. Buskila D, Tenenbaum J: Septic bursitis in human immunodeficiency virus infection. J Rheumatol 1989, 16:1374.